{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:09:45Z","timestamp":1758416985459,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jns.2020.116782","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T13:56:20Z","timestamp":1584626180000},"page":"116782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study"],"prefix":"10.1016","volume":"412","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2256-7281","authenticated-orcid":false,"given":"Camilla","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirio","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pontillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Annicchiarico","family":"Petruzzelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-8180","authenticated-orcid":false,"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Colomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Duro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia Valeria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"De Riso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodolinda","family":"Di Risi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo Brescia","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September","key":"10.1016\/j.jns.2020.116782_bb0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(06)70548-8","article-title":"CNS manifestations of Fabry \u2019 s disease","volume":"5","author":"Fellgiebel","year":"2006","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2020.116782_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2020.116782_bb0015","series-title":"High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening","first-page":"31","volume":"79(July)","author":"Spada","year":"2006"},{"issue":"9813","key":"10.1016\/j.jns.2020.116782_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders\u202f: feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jns.2020.116782_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055565","article-title":"Multifocal white matter lesions associated with the D313Y mutation of the a -Galactosidase A gene","volume":"8","author":"Lenders","year":"2013","journal-title":"PLoS One"},{"issue":"November 19","key":"10.1016\/j.jns.2020.116782_bb0030","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke\u202f: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"issue":"Sep 21","key":"10.1016\/j.jns.2020.116782_bb0035","article-title":"Identification of fabry disease in a tertiary referral cohort of patients with hypertrophic cardiomyopathy","author":"Maron","year":"2017","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2020.116782_bb0040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a Nationwide screening for Anderson-Fabry disease among dialysis patients","volume":"15","author":"Kotanko","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jns.2020.116782_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/TACG.S146022","article-title":"Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype\u2013phenotype correlations","volume":"12","author":"Oliveira","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.jns.2020.116782_bb0050","series-title":"Stroke in Fabry Disease Frequently Occurs Before Diagnosis and in the Absence of Other Clinical Events","first-page":"788","article-title":"Banikazemi M, et al","author":"Sims","year":"2009"},{"key":"10.1016\/j.jns.2020.116782_bb0055","series-title":"Enzyme Replacement Therapy in Fabry Disease","volume":"285(21)","author":"Schiffmann","year":"2001"},{"issue":"1","key":"10.1016\/j.jns.2020.116782_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.20675","article-title":"Parkinsonism and Anderson Fabry\u2019s disease: a case report","volume":"21","author":"Buechner","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.116782_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jns.2008.04.011","article-title":"Decreased activities of lysosomal acid alpha-D-galactosidase a in the leukocytes of sporadic Parkinson\u2019s disease","volume":"271","author":"Wu","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2020.116782_bb0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.dld.2018.02.011","article-title":"Non-specific gastrointestinal features: could it be Fabry disease?","volume":"50","author":"Hilz","year":"2018","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.jns.2020.116782_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejmg.2018.01.006","article-title":"European journal of medical genetics inner ear involvement in Fabry disease: clinical and audiometric evaluation of a large cohort of patients followed in a reference Centre","volume":"61","author":"Rodrigues","year":"2018","journal-title":"Eur J Med Genet."},{"key":"10.1016\/j.jns.2020.116782_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2018.07.011","article-title":"Striatonigral involvement in fabry disease: a quantitative and volumetric magnetic resonance imaging study","volume":"57","author":"Russo","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"137","key":"10.1016\/j.jns.2020.116782_bb0085","first-page":"1","article-title":"Characterization of vertigo and hearing loss in patients with Fabry disease","volume":"13","author":"K\u00f6ping","year":"2018","journal-title":"Orphanet J Rare Dis."},{"issue":"6","key":"10.1016\/j.jns.2020.116782_bb0090","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s13244-018-0664-8","article-title":"Neuroimaging in Fabry disease: current knowledge and future directions","volume":"9","author":"Cocozza","year":"2018","journal-title":"Insights Imaging."},{"issue":"May 2011","key":"10.1016\/j.jns.2020.116782_bb0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-0004.2011.01718.x","article-title":"Fabry disease \u201cthe new great imposter\u201d: results of the French observatoire in internal medicine departments (FIMeD)","volume":"81","author":"Lidove","year":"2012","journal-title":"Clin. Genet."},{"issue":"e71894","key":"10.1016\/j.jns.2020.116782_bb0100","first-page":"1","article-title":"Fabry disease \u2013 underestimated in the differential diagnosis of multiple sclerosis?","volume":"8","author":"Bottcher","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jns.2020.116782_bb0105","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.18632\/oncotarget.23970","article-title":"Fabry disease and multiple sclerosis misdiagnosis\u202f: the role of family history and neurological signs","volume":"9","author":"Colomba","year":"2018","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.jns.2020.116782_bb0110","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/1352458516638747","article-title":"D313Y mutation in the differential diagnosis of white matter lesions: experiences from a multiple sclerosis outpatient clinic","volume":"22","author":"Becker","year":"2016","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.jns.2020.116782_bb0115","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1352458508092355","article-title":"A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?","volume":"14","author":"Invernizzi","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2020.116782_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2015.01.001","article-title":"Fabry disease mimicking multiple sclerosis: lessons from two case reports","author":"Shribman","year":"2015","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.jns.2020.116782_bb0125","first-page":"1","article-title":"Fabry heterozygote mimicking multiple sclerosis","volume":"2","author":"Yau","year":"2017","journal-title":"BMJ Case Rep."},{"issue":"February","key":"10.1016\/j.jns.2020.116782_bb0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.msard.2018.09.019","article-title":"Multiple sclerosis and Fabry disease, two sides of the coin? The case of an Italian family","volume":"26","author":"Russo","year":"2018","journal-title":"Mult Scler Relat Disord."},{"issue":"December 2018","key":"10.1016\/j.jns.2020.116782_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.msard.2019.01.040","article-title":"Misdiagnosis of multiple sclerosis in a female heterozygote with Fabry\u2019s disease","volume":"30","author":"Berger","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.jns.2020.116782_bb0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis\u202f: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.116782_bb0145","series-title":"Canadian Fabry Disease Treatment Guidelines","first-page":"1","volume":"2016","author":"Sirrs","year":"2016"},{"issue":"2","key":"10.1016\/j.jns.2020.116782_bb0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease\u202f: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance \u2606","volume":"177","author":"Smid","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"November 2017","key":"10.1016\/j.jns.2020.116782_bb0155","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.jns.2020.116782_bb0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"DenDunnen","year":"2016","journal-title":"Hum. Mutat."},{"issue":"May","key":"10.1016\/j.jns.2020.116782_bb0165","first-page":"103703","article-title":"Fabry disease caused by the GLA. Phe113Leu (p.F113L) variant: Natural history in males","author":"Oliveira","year":"2019","journal-title":"Eur J Med Genet."},{"issue":"1","key":"10.1016\/j.jns.2020.116782_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2009.41.1.001","article-title":"Effects of a chemical chaperone on genetic mutations in \u03b1 -galactosidase a in Korean patients with Fabry disease","volume":"41","author":"Park","year":"2009","journal-title":"Exp. Mol. Med."},{"issue":"May","key":"10.1016\/j.jns.2020.116782_bb0175","first-page":"1","article-title":"Founder effect of Fabry disease due to p.F113L mutation: clinical profile of a late-onset phenotype","author":"Azevedo","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"June 2013","key":"10.1016\/j.jns.2020.116782_bb0180","article-title":"High variability of fabry disease manifestations in an extended italian family","volume":"2015","author":"Cammarata","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jns.2020.116782_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00508-017-1291-y","article-title":"Clinical-pathological conference series from the medical University of Graz Case no 153: a 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome","volume":"130","author":"Fabian","year":"2018","journal-title":"Wien KlinWochenschr."},{"key":"10.1016\/j.jns.2020.116782_bb0190","series-title":"Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene","first-page":"395","author":"Lukas","year":"2012"},{"key":"10.1016\/j.jns.2020.116782_bb0195","volume":"63","author":"Nance","year":"2015","journal-title":"Later-Onset Fabry Dis."},{"key":"10.1016\/j.jns.2020.116782_bb0200","series-title":"Fabry disease mimicking multiple sclerosis","first-page":"361","volume":"109","author":"Saip","year":"2007"},{"issue":"Nov18","key":"10.1016\/j.jns.2020.116782_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.msard.2019.06.008","article-title":"Multiple sclerosis and Fabry disease - diagnostic \u201cmixup\u201d","volume":"34","author":"Jurasic","year":"2019","journal-title":"Mult Scler Relat Disord."},{"issue":"2010","key":"10.1016\/j.jns.2020.116782_bb0210","first-page":"1","article-title":"The large phenotypic spectrum of Fabry disease requires graduated diagnosis and personalized therapy\u202f: a meta-analysis can help to differentiate missense mutations","volume":"17","author":"Citro","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2020.116782_bb0215","first-page":"99","article-title":"Lyso-Gb3 indicates that the alpha-Galactosidase a mutation D313Y is not clinically relevant for Fabry disease","volume":"1993","author":"Niemann","year":"2012","journal-title":"JIMD Rep."},{"issue":"11","key":"10.1016\/j.jns.2020.116782_bb0220","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/1352458512442756","article-title":"Spatiotemporal distribution of white matter lesions in relapsing\u2013remitting and secondary progressive multiple sclerosis","volume":"18","author":"Filli","year":"2012","journal-title":"Mult. Scler. J."},{"issue":"11","key":"10.1016\/j.jns.2020.116782_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1121","article-title":"Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis","volume":"8","author":"Ugga","year":"2018","journal-title":"Brain Behav."},{"issue":"6","key":"10.1016\/j.jns.2020.116782_bb0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00234-017-1829-8","article-title":"Corpus callosum involvement\u202f: a useful clue for differentiating Fabry disease from multiple sclerosis","volume":"59","author":"Cocozza","year":"2017","journal-title":"Neuroradiology."},{"key":"10.1016\/j.jns.2020.116782_bb0235","first-page":"1","article-title":"Spatial distribution of multiple sclerosis lesions in the cervical spinal cord","volume":"1","author":"Eden","year":"2019","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jns.2020.116782_bb0240","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3174\/ajnr.A5420","article-title":"Redefining the Pulvinar sign in Fabry disease","volume":"38","author":"Cocozza","year":"2017","journal-title":"Am. J. Neuroradiol."},{"issue":"15","key":"10.1016\/j.jns.2020.116782_bb0245","first-page":"1","article-title":"MRI criteria for the diagnosis of multiple sclerosis\u202f: MAGNIMS consensus guidelines","volume":"4422","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.116782_bb0250","series-title":"EVIDENCE-BASED GUIDELINES MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis \u2014 clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015"},{"issue":"10","key":"10.1016\/j.jns.2020.116782_bb0255","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","article-title":"Review MRI and the diagnosis of multiple sclerosis\u202f: expanding the concept of \u201c no better explanation\u201d","volume":"5","author":"Charil","year":"2006","journal-title":"Lancet Neurol."},{"issue":"May","key":"10.1016\/j.jns.2020.116782_bb0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.msard.2018.05.011","article-title":"2017 McDonald diagnostic criteria: a review of the evidence","volume":"24","author":"Mcnicholas","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.jns.2020.116782_bb0265","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease\u202f: characterization of a -Galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"492","author":"Yasuda","year":"2003","journal-title":"Hum. Mutat."},{"issue":"22","key":"10.1016\/j.jns.2020.116782_bb0270","doi-asserted-by":"crossref","first-page":"e2527","DOI":"10.1212\/WNL.0000000000007573","article-title":"\u201cBetter explanations\u201d in multiple sclerosis diagnostic workup. A 3-year longitudinal study","volume":"92","author":"Calabrese","year":"2019","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:50:38Z","timestamp":1758383438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20301180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":54,"alternative-id":["S0022510X20301180"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116782","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116782"}}